Fueled by a doubling in its sales of vaccines, Merck & Co. today reported a 63 percent rise in net income for the third quarter.
Merck, whose vaccine operations are headquartered in West Point, Montgomery County, made more money because it cut costs by two percent as revenues rose by 12 percent.
Driving sales for the the third largest U.S. drugmaker were Merck's newer, heavily marketed drugs, including its top seller, the asthma drug Singulair, the diabetes medicine Januvia and the HPV vaccine Gardasil.
http://www.philly.com/inquirer/breaking/business_breaking/20071022_Mercks_net_income_soars_63_.html
No comments:
Post a Comment